The world’s leading manufacturer of DNA sequencing systems will pay $9.8 million to resolve allegations that it knowingly sold products with security vulnerabilities to federal agencies, Rhode ...

The U.S. alleged the company knowingly sold genetic-sequencing systems with software vulnerabilities to federal agencies.

Biotech firm Illumina has agreed to cut the US government a check for the eminently affordable amount of $9.8 million to ...

Genomics sequencing firm Illumina Inc. has agreed to pay $9.8 million to resolve False Claims Act whistleblower allegations ...

Illumina Inc., a leading biotechnology company, has agreed to pay $9.8 million to settle allegations that it sold genomic ...

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 3% year on year to $1.06 billion. Its non-GAAP profit of $0.36 per share was 64.4% below ...

Illumina has agreed to pay $9.8 million in a settlement with the Justice Department over allegations it sold federal agencies genomic sequencing systems with cybersecurity vulnerabilities.

SAN DIEGO (AP) — SAN DIEGO (AP) — Illumina Inc. (ILMN) on Thursday reported second-quarter earnings of $235 million. On a per-share basis, the San Diego-based company said it had net income of $1.49.

Illumina introduces next generation cancer research assay, TruSight Oncology 500: San Diego Friday, August 1, 2025, 12:00 Hrs [IST] Illumina Inc., a biotechnology company develops ...

Return on Equity (ROE): Waters's ROE stands out, surpassing industry averages. With an impressive ROE of 6.4%, the company demonstrates effective use of equity capital and strong financial performance ...

Illumina Inc. (NASDAQ: ILMN), a global leader in sequencing technology, announced today that Illumina India has won the Top GCC Award at the 2025 GCC Workplace Awards, hosted by the Zyoin Group. The ...